More layoffs

[anonymous]

The 'get ready, you will find out more tomorrow' emails went out today, so it might get bloody on Wednesday. Director/Senior Director leaders with teams of people under them heard nothing about what is coming.

Updated: Biogen makes cuts across its research unit, shifting focus to ‘external opportunities’

 

[anonymous]

I am learning this company does not make smart moves. They way overpaid for Sky, and now they're in a panic because...duh...it's rare. No one will be making a bonus.
Then offering to buyout sage. Sure, they have their hand in the cookie jar, but cut your losses. They are in the red of over spending.
Alzheimers MOA is complete crap. Everything needs to be scrapped there. Whatever used to be known as a good company, is so far gone now. Please lay us off.

Even Michael Ehlers has already moved on from the amyloid plaque MOA hypothesis!

 

[anonymous]

I am learning this company does not make smart moves. They way overpaid for Sky, and now they're in a panic because...duh...it's rare. No one will be making a bonus.
Then offering to buyout sage. Sure, they have their hand in the cookie jar, but cut your losses. They are in the red of over spending.
Alzheimers MOA is complete crap. Everything needs to be scrapped there. Whatever used to be known as a good company, is so far gone now. Please lay us off.

Even Michael Ehlers has already moved on from the amyloid tau plaque MOA hypothesis!

 

[anonymous]

Updated: Biogen makes cuts across its research unit, shifting focus to ‘external opportunities’

With the government making so much dei administrative talent available, biogen had to lay off research to double down on its dei for growth hypothesis. Dei makes everything better and biogen hr knows this is the way. Karen nirvana on the way.

 

[anonymous]

Go woke, go broke.

 

[anonymous]

Go woke, go broke.

Woke? Meaning?

 

[anonymous]

I’ve heard from multiple sources now that it’s happening this summer. Anyone else have intel?

 

[anonymous]

Yes, mainly in MS. Only 1 rep - consolidation of territories - less managers…

Clearly read the earnings report - expenses rose and took a chunk out of profit margin - MS down another 11 percent

Biogen is redefining itself clearly

 

[anonymous]

Yes, mainly in MS. Only 1 rep - consolidation of territories - less managers…

Clearly read the earnings report - expenses rose and took a chunk out of profit margin - MS down another 11 percent

Biogen is redefining itself clearly

The minute CV announces another overpriced acquisition that makes no sense, you better get interviewing. It will be the savings from your cuts that fund it.

Enjoy the “strategic accountant”

 

[anonymous]

Yes, mainly in MS. Only 1 rep - consolidation of territories - less managers…

Clearly read the earnings report - expenses rose and took a chunk out of profit margin - MS down another 11 percent

Biogen is redefining itself clearly

I’m hearing more deep cuts in Med Affairs. No need for MSLs when things are going haywire. We’ve already been through this so many times. Don’t know what value they add anyways. I can’t think of the last time I even saw or talked to my MSL, except at a meeting or convention—they’ve been AWOL. What are those people anyways? Ghosts?